Company Profile
PTM Biolabs Inc
Company Overview
The mission of PTM Biolabs, a rapidly growing company, is to address the unmet needs of life sciences and personalized medicine, by supply of innovative technologies and services in the fields of antibody reagents and proteomic analysis in post-genomic era. Our products and services have been profoundly expediting research for protein post translational modifications (PTMs), epigenetics, protein quantification, drug target screening and biomarker discovery.
Company History
Founded in 2010, PTM Biolabs is dedicated to technology development of protein post translational modifications (PTMs). We have become the powerhouse for the following technologies: development of high-quality epigenetic antibodies targeting specific PTM pathways and histone codes; and high-sensitivity proteomic platform for preclinical pharmaceutical R & D.
We are an organization founded by scientists, built on solid science and driven by continuous innovation. Our keen devotion to scientific discoveries is demonstrated by rich history of publications in renowned scientific journals. In the past four years, over 30 peer reviewed publications have been co-authored by CEO or other scientists in our organization.
We lay the corporation corner stone on technological advancements. PTM Biolabs now presents the largest collection of unique antibodies detecting 20 different PTM pathways and over 200 histone codes. The world's largest acetylome in both mammalian cells and prokaryotic cells were both identified using our all-in-one proteomic technology.
Notable Products / Brands
PTM Biolabs
Notable Accomplishments / Recognition
Our innovative technologies and products in the field of MS based proteomic analysis have been profoundly expediting research for protein post translational modifications (PTMs), epigenetics, protein quantification, drug target screening, and biomarker discovery.